SCHEMBL29964482

SCHEMBL29964482

CC(C)(C)OC(=O)N1CCN(Cc2cccc(B3OC(C)(C)C(C)(C)O3)c2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLS O94925 2/20 0.47
USP30 Q70CQ3 1/20 0.43
MGLL Q99685 1/20 0.42
LPL P06858 1/20 0.42
LIPG Q9Y5X9 1/20 0.42
ACKR3 P25106 1/20 0.42
CHRM2 P08172 1/20 0.42
CHRM4 P08173 1/20 0.42
CHRM1 P11229 1/20 0.42
CHRM3 P20309 1/20 0.42
PRMT5 O14744 1/20 0.41
WDR77 Q9BQA1 1/20 0.41
VEGFA P15692 1/20 0.41
EGLN1 Q9GZT9 1/20 0.41
KDM1A O60341 2/20 0.40
ALDH1A1 P00352 1/20 0.40
HTT P42858 1/20 0.40
TBK1 Q9UHD2 1/20 0.40
TP53 P04637 2/20 0.40
THRB P10828 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3041956 1.00 GLS (0.47) GLSUSP30MGLLLPLLIPG
SCHEMBL28327826 0.90 LIPG (0.46) GLSUSP30LPLLIPGACKR3
SCHEMBL3123517 0.87 USP30 (0.50) GLSUSP30MGLLLPLLIPG
SCHEMBL3045151 0.85 LIPG (0.47) LPLLIPGALDH1A1HTT
SCHEMBL31019106 0.84 IDO1 (0.41) GLSUSP30MGLLCHRM2CHRM4
SCHEMBL1363047 0.84 USP30 (0.40) GLSUSP30MGLLLPLLIPG
SCHEMBL8020161 0.84 USP30 (0.40) GLSUSP30MGLLLPLLIPG
SCHEMBL1363539 0.84 USP30 (0.48) USP30LPLLIPGTP53THRB
SCHEMBL24764741 0.82 IDO1 (0.45) GLSUSP30MGLLCHRM2CHRM4
SCHEMBL521045 0.82 GPR119 (0.51) USP30ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025106910-A1 DEGRADER MOLECULES TARGETING ANDROGEN RECEPTOR FLARE THERAPEUTICS INC. (US) 2025-05-22 WO disclosed
WO-2022226668-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2022-11-03 WO disclosed